Rubella Treatment Market Size

  • Report ID: 3621
  • Published Date: Aug 26, 2024
  • Report Format: PDF, PPT

Rubella Treatment Market Size

Rubella Treatment Market size is projected to witness around 6.4% CAGR during the forecast period i.e., between 2024-2036. The growth of the market can be largely attributed to the growing number of cases of rubella that results from high transmission ability of togavirus via air. Along with this, launch of several government initiatives associated with research and development of sophisticated diagnostic techniques, especially in emerging economies such as China and India, is expected to offer abundant opportunities for market growth in the near future. Furthermore, high risk of major complications in rubella infected pregnant women, and escalating government initiatives to include rubella vaccinations in national health programs, targeted mainly towards children and young adults, are also significant factors projected to augment the growth of the rubella treatment market in the upcoming years. According to the World Health Organization, 168 out of 194 countries introduced rubella vaccines in their health programs and the global coverage was about 69 percent as of December 2018. 14,621 cases of the disease were reported in 151 countries that same year.


Rubella Treatment Market Graph
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 3621
  • Published Date: Aug 26, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Rubella Treatment Market size is projected to witness around 6.4% CAGR during the forecast period i.e., between 2024-2036.

The market growth is driven by growing incidences of rubella worldwide, and government initiatives about research and development of sophisticated diagnostic techniques.

North America industry is estimated to hold largest revenue share by 2036, on account of growing levels of awareness about rubella, high healthcare spending, and rising number of drug manufacturing facilities in the region.

The major players in the market are Novartis AG, Pfizer Inc., Johnson & Johnson Services, Inc., GlaxoSmithKline PLC, and others.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample